Скачать
5-year follow-up: dabrafenib plus trametinib reduces relapse risk in melanoma
Автор: VJOncology
Загружено: 2021-04-16
Просмотров: 649
Описание: Georgina Long, PhD, MBBS, FRACP, University of Sydney, Sydney, Australia, talks on adjuvant targeted therapies for patients with melanoma, highlighting five-year results of dabrafenib combined with trametinib versus placebo in resected stage III melanoma (NCT01584648). Five-year results are consistent with three-year results, reporting a relapse-free survival benefit with a risk reduction of 50%. This interview took place during the 10th World Congress of Melanoma in conjunction with the 17th EADO Congress Interactive Virtual Meeting.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
